White Papers

1. Why Smarter Handling Can Save Your Production Line From Inefficiencies 11/3/2026

   Line performance in packaging is often decided between machines, not within them. Treating handling as a discipline rather than an afterthought changes how flow, protection, and growth are planned.

2. Advancing ADCs: From Concept To Commercialization 11/3/2026

   ADC programs move fastest when payload-linker strategy, route design, conjugation, and drug product are planned together, with timelines and scale-up capacity shaping choices from the earliest development stages.

3. Managing Risks With Potent Pharmaceutical Products 11/2/2026

   Manufacturing potent medications safely requires specialized containment, toxicology expertise, and strict contamination controls to ensure compliance, product quality, and worker safety.

4. Is Your API Right For A Soft Gel Capsule? 11/2/2026

   Soft gel delivery systems can enhance bioavailability, enable controlled release, support combination dosing, and handle potent compounds while improving stability and patient adherence.

5. Ensuring Business Continuity In Your Pharmaceutical Commercial Supply 11/2/2026

   Drug shortages demand resilient supply chains and strategic partnerships. Learn how experienced manufacturers help mitigate risks and ensure reliable supply.

6. 10 Qualities Your CDMO Should Have For An Oral Dose Tech Transfer 11/2/2026

   Choose a manufacturing partner that supports every development phase with regulatory expertise, supply chain resilience, and formulation know-how.

7. Biomanufacturing Readiness: A Validation Model For Multiproduct Facilities 10/26/2026

   Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

8. Comparing Nebulized Hydrogen Peroxide (NHP) And Vaporized Hydrogen Peroxide (VHP) For Isolator Decontamination 10/19/2026

   Compare Nebulized and Vaporized Hydrogen Peroxide efficacy, cycle times, and validation challenges inside pharmaceutical isolators to optimize your aseptic processing turnaround.

9. Connected By Design: Laboratory Automation And Digital Transformation Strategy 10/19/2026

   Task-level automation delivers isolated gains, but the larger payoff in GxP laboratories comes from connecting instruments, systems, and data into workflows where samples move with minimal human handoffs.

10. How To Prepare For Risk-based Biological Reactivity Testing 10/16/2026

    Biological reactivity testing is moving from material classification toward risk-based evaluation, where chemistry data, exposure, and application determine what evidence is enough for each material.